BioLamina, a Stockholm-based BioTech scale-up specialising in matrix biology and cell culture, has secured a €20 million financing commitment from…
Read More

BioLamina, a Stockholm-based BioTech scale-up specialising in matrix biology and cell culture, has secured a €20 million financing commitment from…
Read More